Steven Cohen Roivant Sciences Ltd. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 647,126 shares of ROIV stock, worth $7.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
647,126
Previous 647,126
-0.0%
Holding current value
$7.3 Million
Previous $6.84 Million
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding ROIV
# of Institutions
308Shares Held
496MCall Options Held
989KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$805 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$780 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$753 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$399 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$331 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.95B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...